Millennium Management’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$353K Buy
2024
Q4
Sell
2024
Q3
$278K Buy
2024
Q2
Sell
2024
Q1
$683K Buy
2023
Q1
Sell
2022
Q4
$226K Buy